Company Overview and News

 
Trading ideas: Scientex, Advancecon, Bina Puri, Titijaya, Muhibbah

2018-03-23 thestar.com.my
KUALA LUMPUR: Scientex Bhd , Advancecon Holdings Bhd, Bina Puri Holdings Bhd , Titijaya Land Bhd and Muhibbah Engineering (M) Bhd are among the stocks to watch on Friday, according to JF Apex Research.
Upvote Downvote

 
Bina Puri, Titijaya in joint venture

2018-03-23 thestar.com.my
PETALING JAYA: Bina Puri Holdings Bhd and Titijaya Land Bhd are entering into a new joint venture (JV) to develop a mixed residential and commercial project on 11.2 acres of land in Brickfields, Kuala Lumpur.
Upvote Downvote

 
Titijaya has ongoing, future projects of RM12.3b GDV

2018-01-13 themalaymailonline
KUALA LUMPUR, Jan 13 — Titijaya Land Bhd, a leading Malaysian property developer, has currently ongoing and future projects of about RM2.3 billion and RM10 billion in gross development value (GDV) respectively.
Upvote Downvote

 
Ringgit to appreciate further, predicts minister

2018-01-13 themalaymailonline
Second Finance Minister, Datuk Seri Johari Abdul Ghani expects the ringgit to appreciate further against the greenback amid the country’s positive economic outlook. — File picture by Yusof Mat IsaKUALA LUMPUR, Jan 13 — The ringgit can be expected to appreciate further against the greenback amid the country’s positive economic outlook, says Second Finance Minister, Datuk Seri Johari Abdul Ghani.
Upvote Downvote

 
Trading ideas: Serba Dinamik, Yinson, Gas Malaysia, Titijaya Land

2017-11-30 thestar.com.my
KUALA LUMPUR: Serba Dinamik Holdings Bhd, Yinson Holdings Bhd , Gas Malaysia, Titijaya Land are among the stocks to watch on Thursday, according to JF Apex Research.
Upvote Downvote

 
Breakfast briefing: Thursday, November 9

2017-11-09 thestar.com.my
MarketWatch: Wall Street closed at a record high on Wednesday as videogame makers rallied and Apple’s market value climbed above US$900 billion. The DJIA edged up 0.03% to end at 23,563.36, the S&P 500 gained 0.14% to 2,594.38 and the Nasdaq added 0.32% to 6,789.12. - Reuters
Upvote Downvote

 
Titijaya gets compensation

2017-10-24 thestar.com.my
KUALA LUMPUR: Titijaya Land Bhd has announced that its wholly-owned subsidiary, Shah Alam City Centre Sdn Bhd, has received a notice pursuant to the Land Acquisition Act 1960 from Petaling Land Administrator on Oct 11, 2017, on the compensation of temporary land occupation/ usage of a land in Shah Alam for RM65mil.
Upvote Downvote

 
Trading ideas: Berjaya Food, Kimlun, Hibiscus Petroleum

2017-09-18 thestar.com.my
KUALA LUMPUR: JF Apex expects Berjaya Food , Kimlun, Hibiscus Petroleum and Berjaya Corp to be among the stocks to see trading interests on Monday.
Upvote Downvote

 
Breakfast briefing: Monday, September 18

2017-09-18 thestar.com.my
MarketWatch: US equity investors could rotate out of high-yielding sectors and into stocks of banks, which would benefit from the next leg up in interest rates, after the Federal Reserve’s policy-setting meeting wraps up on Wednesday. If the Fed this week gives a nod to rising inflation or focuses its trimmed-down bond buying on longer-dated bonds as it winds down its balance sheet, there could be a shift around of preferred sectors, investors said.
Upvote Downvote

 
Foreign investor eyes stake in Titijaya

2017-09-17 thestar.com.my
When contacted by StarBiz, Titijaya deputy group managing director Lim Poh Yit(filepic) confirmed that the company was in discussions with several parties but he declined to elaborate.
Upvote Downvote

 
Titijaya Land launches The Shore project in Sabah

2017-07-11 thestar.com.my
At the ground-breaking ceremony are (from left) Local Government and Housing Minister of Sabah Datuk Seri Hajiji Noor and Titijaya Land group managing director Tan Sri Lim Soon Peng.
Upvote Downvote

 
M-Mode to get new shareholder, business revamp

2017-05-31 thestar.com.my
PETALING JAYA: There was an off-market transaction of 61.068 million shares or a 37.5% stake of M-Mode Bhd at the price of 30 sen a share yesterday, suggesting that its single largest shareholder and group managing director Datuk Lim Thean Keong is exiting the company.
Upvote Downvote

 
Titijaya to tie up with CREC in RM575mil Sabah property project

2017-05-15 thestar.com.my
MoU signed: (from left) Titijaya deputy group MD Lim Poh Yit, Tan Sri Lim Soon Peng, Najib, China Railway Dongfang Group MD Cai Zemin and China Railway Engineering Corp (M) Sdn Bhd MD Wang Youping at the MoU signing in Beijing.
Upvote Downvote

 
Titijaya and China Railway sign deal for The Shore

2017-03-01 thestar.com.my
Lim: ‘With the strong CREC presence in China, The Shore will attract more investors from China.'
Upvote Downvote

 
KLCI to trend sideways, hover just below 1,700 level

2017-02-28 theedgemarkets
KUALA LUMPUR (Feb 28): The FBM KLCI is expected to trend sideways today and consolidate, and likely hover just below the 1,700-point level.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...